Sutent and Choledocholithiasis - a phase IV clinical study of FDA data

Summary:

Choledocholithiasis is reported as a side effect among people who take Sutent (sunitinib malate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Blopress, and have Metastatic renal cell carcinoma.

The phase IV clinical study analyzes which people have Choledocholithiasis when taking Sutent. It is created by eHealthMe based on reports of 44,359 people who have side effects when taking Sutent from the FDA, and is updated regularly.

What is Sutent?

Sutent has active ingredients of sunitinib malate. It is often used in renal cell carcinoma. eHealthMe is studying from 44,554 Sutent users. Check the latest studies of Sutent.

What is Choledocholithiasis?

Choledocholithiasis (stones in the common bile duct) is found to be associated with 599 drugs and 961 conditions by eHealthMe. Check the latest studies of Choledocholithiasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

44,359 people reported to have side effects when taking Sutent.
Among them, 16 people (0.04%) have Choledocholithiasis.

Among these 16 people:

How long have people been on Sutent when they have Choledocholithiasis? *

What is the gender of people who have Choledocholithiasis when taking Sutent? *

female: 7.69 %
male: 92.31 %

What is the age of people who have Choledocholithiasis when taking Sutent? *

What are other drugs people take besides Sutent? *

What are other side effects people have besides Choledocholithiasis? *

Cholecystitis Acute (rapid infection of gallbladder): 6 people, 37.50%
Fever: 5 people, 31.25%
Stomatitis (inflammation of mucous membrane of mouth): 4 people, 25.00%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 4 people, 25.00%
Gingivitis (inflammation of gums): 3 people, 18.75%
Pancreatic Enzymes Increased: 3 people, 18.75%
Gums - Swollen: 3 people, 18.75%
High Blood Pressure: 3 people, 18.75%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 18.75%
Cholecystitis (infection of gallbladder): 3 people, 18.75%

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 5 people, 31.25%
Gastrointestinal Stromal Tumor: 4 people, 25.00%
Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 1 person, 6.25%
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Sutent and have Choledocholithiasis?

- Check whether Choledocholithiasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sutent:

Sutent (44,554 reports)

Browse all side effects of Sutent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Choledocholithiasis:

Choledocholithiasis (599 drugs)

Browse all the conditions that are associated with Choledocholithiasis:

Choledocholithiasis (961 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sunitinib malate (the active ingredients of Sutent) and Sutent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.